Roche Holding AG (XSWX:ROG)
CHF 251 0 (0%) Market Cap: 201.45 Bil Enterprise Value: 231.01 Bil PE Ratio: 18.96 PB Ratio: 6.91 GF Score: 93/100

Roche Holding AG Virtual Early Drug Development gRED Call Transcript

Feb 18, 2020 / 02:30PM GMT
Release Date Price: CHF345.55 (+0.66%)
Operator

Ladies and gentlemen, welcome to the Roche Virtual Early Drug Development gRED Event 2020 Conference Call. I am Sandra, the Chorus Call operator. (Operator Instructions) The conference must not be recorded for publication or broadcast.

At this time, it's my pleasure to hand over to Karl Mahler, Head of Investor Relations and Roche Group Planning. Please go ahead, sir.

Karl Mahler
Roche Holding AG - Head of IR

Yes. Thanks a lot, Sandra. Good afternoon, good morning, ladies and gentlemen. Warm welcome from our side here from Basel. This is actually the second event we do for those -- for these kind of more fundamental insights into the Roche, where we had one done for pRED a few weeks ago. We will have one in May on digital -- digitization. And today, we want to focus on Genentech's early research and development known as gRED.

We have with us today Mike Varney. He is the Head of Genentech Research and Early Development of the entire setup. He will give us an overview and strategic insights. We have Andy Chan with us for the non-oncology

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot